MDL | - |
---|---|
Molecular Weight | 459.84 |
Molecular Formula | C21H29Cl3N4O |
SMILES | [H]Cl.[H]Cl.O=C(NC1=CC=C([C@@H]2C[C@H]2N)C=C1)C(C=C3)=CC=C3N4CCN(C)CC4.[H]Cl |
DDP-38003 trihydrochloride is an novel, orally available inhibitor of histone lysine-specific demethylase 1A ( KDM1A/LSD1 ) with an IC 50 of 84 nM.
IC50: 84 nM (KDM1A/LSD1) [1]
DDP-38003 inhibits KDM1A with an IC 50 of 84 nM. DDP-38003 is more active in reducing the colony forming ability and in inducing thedifferentiation of THP-1 cells compared to the 1R, 2S analogue [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
DDP-38003 exhibits in vivo efficacy after oral administration, determining a 62% increased survival in mouse leukemia models with evidence of KDM1A inhibition. The half life of DDP-38003 is 8 h. A significant dose dependent increase of mice survival is obtained by DDP-38003 treatment. The survival rate increases 35% and 62% at the dose of 11.25 and 22.50 mg/kg, respectively. DDP-38003 is a potential oral anticancer agent [1] .
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Solid
Room temperature in continental US; may vary elsewhere.
4°C, stored under nitrogen
* In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen)
DMSO : 100 mg/mL ( 217.47 mM ; Need ultrasonic)
H 2 O : 50 mg/mL ( 108.73 mM ; Need ultrasonic)
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.1747 mL | 10.8733 mL | 21.7467 mL |
5 mM | 0.4349 mL | 2.1747 mL | 4.3493 mL |
10 mM | 0.2175 mL | 1.0873 mL | 2.1747 mL |
Add each solvent one by one: PBS
Solubility: 50 mg/mL (108.73 mM); Clear solution; Need ultrasonic
Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)
Solubility: ≥ 2.5 mg/mL (5.44 mM); Clear solution